Page 46 - Rapid Review of ECG Interpretation in Small Animal Practice, 2nd Edition
P. 46

Treatment of Arrhythmias




           Table 4.1 Drugs for treatment of supraventricular arrhythmias
  VetBooks.ir  Drug      Administration per os    Parenteral administration Comments

           Diltiazem HCl:  Dog: 0.5–2 mg/kg TID
                                                                         Intravenous dosing can cause
                                                  Dog: 0.05–0.25 mg/kg IV
            (Cardizem);   Dilacor XR: 2.5–4.5 mg/kg    bolus followed by  transient hypotension and
            (Extended    BID                      CRI: 2–6 µg/kg/min      AV nodal block
            release:     Cat:                     Cat: 0.1–0.4 mg/kg, IV
            Dilacor XR)  Dilacor XR: 30–60 mg/cat   bolus over ∼1 minute
                         SID to BID                followed by
                                                  CRI: Titrate to effect
                                                   2–6 µg/kg/min
           Digoxin       Dog: 0.0025–0.0035 mg/kg                        Do not exceed 0.25 mg per
                                        2
                         BID (or 0.11 mg/m  BID)                          dog BID
                         Cat: 0.03125 mg/cat every
                         other day
           Procainamide                           Dog: 5–15 mg/kg IV bolus  Can decrease contractility
                                                   slowly over 2 minutes,
                                                   CRI: 25–50 µg/kg/min
           Esmolol HCl                            Dog and cat: 50–100 µg/  Can decrease contractility;
                                                   kg IV bolus, repeat up to   can combine with any other
                                                   max 500 µg/kg          IV antiarrhythmic; use with
                                                  CRI: Titrate to effect:   caution in combination with
                                                   50–200 µg/kg/min       procainamide
           Atenolol      Dog: 0.5–2 mg/kg SID to BID                     Titrate to effect; can decrease
                         Cat: 6.25–12 mg SID to BID                       contractility
           Amiodarone    Dog: 5–15 mg/kg BID for   Dog: 2 mg/kg IV bolus   Can combine with atenolol for
                         1–2 weeks (loading dose),   slowly over 10 min   refractory supraventricular
                         then 6–15 mg/kg SID      CRI: 0.8 mg/kg/h for 6 h,   tachycardia
                         (maintenance dose)        the 0.4 mg/kg/h       Aqueous (water-based)
                                                                          formulations are better
                                                                          tolerated than polysorbate
                                                                          80/alcohol-based
                                                                          formulations
           Sotalol       Dog: 1.5–2.5 mg/kg BID
                         Cat: 10 mg/cat BID
           Abbreviations: CRI, continuous rate infusion; IV, intravenous.



          primary AF is avoidance of structural or functional   Focal (ectopic) atrial tachycardia (FAT)
          myocardial remodeling that results secondary to   Ideally, the rapidly firing atrial focus, which is the
          chronic AF. Recurrence of AF after cardioversion   underlying mechanism, is suppressed using sotalol,
          is unpredictable. Pre-treatment  with amiodarone   amiodarone, or procainamide (see  Table  4.1).
          or  sotalol  may  improve  the  chances  of  successful   However, similar to  AF and  AFL, slowing of
          cardioversion.                                 AV node conduction  with a CCB or BB  can be
                                                         used either with or without these drugs to reduce
          Atrial flutter (AFL)                           the ventricular response rate. Digoxin is usually
          Treatment of AFL is similar to treatment of AF, and   ineffective for management of FAT.
          ventricular rate control via slowing of the AV node
          with a CCB or BB is commonly performed (for    Atrioventricular re-entry tachycardia (AVRT)
          drug dosages, see treatment for AF and Table 4.1).   Treatment of  AVRT, especially in animals with
          Medical conversion of AFL to sinus rhythm with   syncope, lethargy, or congestive heart failure,
          antiarrhythmic drugs such as a potassium-channel   typically involves a CCB or BB. For acute
          blocker (sotalol) is rarely achieved in dogs.   management of dogs with incessant tachycardia,
          Radiofrequency ablation has been used successfully   intravenous diltiazem or esmolol is commonly
          in a small number of dogs.                     administered, followed by titration to oral dosing.
                                                                                                         33
   41   42   43   44   45   46   47   48   49   50   51